Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8486422 | Vaccine | 2017 | 6 Pages |
Abstract
Active participant-reported data provided timely vaccine brand-specific safety information. Our surveillance system has particular utility in monitoring the safety of influenza vaccines, given that they may vary in composition annually.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alexis Pillsbury, Helen Quinn, Patrick Cashman, Alan Leeb, Kristine Macartney, on behalf of the AusVaxSafety consortium on behalf of the AusVaxSafety consortium,